Search Results for covid

Name: Bristows
Price range: $$$

VIEW:

Claire Smith

People

Erik Müürsepp

People

Lucie Fortune

People

Simon McDougall

People

Chartered Institute of Taxation (CIOT)’s...

10.08.2020

Event

Pharmaceutical round-up: competition, regulation...

03.07.2020

Event

The latest on competition law in the COVID-19...

22.05.2020

Event

One Nucleus’ Building Life Science Adventures...

09.02.2022

Event

Will AI save the world from another pandemic?

06.04.2021

Event

LESI 2021 Annual Conference: Maximizing the value...

12.05.2021

Event

OxView’s 8th Intellectual Property and...

08.06.2023

Event

Patent review of the year seminar

17.02.2020

Event

Transparency – How to get the message across

18.06.2020

Event

Advanced EU Competition Law: Digital edition

28.08.2020

Event

SCL Tea & Tech Two

04.02.2021

Event

The modern space race: Vaccine rollout and the...

02.06.2021

News

UK government approach to COVID-19 therapeutics...

22.05.2020

News

Public Health England ‘approves’ Roche...

15.05.2020

News

Collaboration: Sustainable future or dangerous...

27.04.2021

News

Animal vaccines: COVID-19 and beyond

16.07.2021

News

Spotlight on mRNA – IP landscape

08.10.2021

News

Spotlight on mRNA – Regulation of mRNA vaccines...

28.10.2021

News

Releasing the Therapeutic GMO

14.04.2022

News

The importance of pandemic preparedness

26.09.2022

News

European Commission resurrects comfort letters to...

01.05.2020

News

COVID-19 and its impact on Competition Law for...

14.04.2020

News

In response to COVID-19, the European Commission...

04.05.2020

News

COVID-19: Key implications for digital...

19.05.2020

News

UK and Europe back exemptions – more medical...

31.03.2020

News

MHRA approves Janssen COVID-19 vaccine

01.06.2021

News

UK announce new ventilator requirements in the...

26.03.2020

News

mRNA patent litigation…the new patent wars?

16.03.2023

News

How is COVID-19 impacting competition law for the...

23.04.2020

News

Government updates ventilator challenge minimum...

17.04.2020

News

Spotlight on mRNA – Recent deal activity

21.10.2021

News

The small difference making big waves: Why...

27.05.2021

News

Charlie French quoted in the Financial Times and...

29.04.2024

News

Priorities for academic organisations in...

07.05.2020

News

Spotlight on mRNA – What is mRNA and what...

24.09.2021

News

Avoiding bias and increasing diversity in AI and...

11.05.2021

News

Q&A – The industry perspective

14.06.2022

News

Viral vectors: shortages and innovation

30.03.2022

News

Five Life Sciences trends for 2022

31.01.2022

News

How COVID-19 has impacted the adtech industry

29.04.2020

News

Smoother sailing for sanitisers

31.03.2020

News

Commission delays MDR by 12 months

26.03.2020

News

Fortnite takes on Apple’s App Store in Epic...

18.08.2020

News

AI and medical devices – Our experts answer...

09.03.2021

News

Gilead’s remdesivir granted conditional...

03.07.2020

News

Government writes to medicine suppliers...

10.08.2020

News

Looking ahead to the EU In Vitro Diagnostic...

26.04.2022

News

Spin-outs: What will 2021 hold for UK...

01.01.2021

News

Spotlight on mRNA – A brief history of mRNA...

24.09.2021

News

Will the new pharmaceutical strategy for Europe...

29.04.2021

News

Notified Bodies – An update

20.04.2021

News

CLIP of the month: Could patent pools help combat...

28.04.2020

News

Uncertain times: Changes to the UK’s tax regime

01.02.2021

News

Biotech is in for a rollercoaster 2021

22.04.2021

News

Fiona Nicolson launches three briefings, written...

05.05.2020

News

Avoiding bias and increasing diversity in AI and...

12.05.2021

News

European Commission publishes Common...

01.09.2020

News

Regulatory T cells: the next wave of cell therapy

21.06.2022

News

CRISPR-Cas9 – from Nobel prizes to priority

20.05.2021

News

‘Full throttle’: venture capital in...

07.04.2022

News

The UK’s genomic future

19.10.2020

News

CLIP of the month: safeguarding pro-competitive...

03.12.2021

News

The regulation of software medical devices

22.05.2020

News

Implementation deadlines for the EU In Vitro...

29.01.2024

News

Innovation Passports and the ILAP: A new and...

12.03.2021

News

BIA announces another record year of UK biotech...

02.02.2021

News

Test and trace apps: are there any privacy...

12.11.2020

News

MDR postponement staves off Swixit – for now

22.04.2020

News

A growing trend of smaller, early-stage...

06.05.2021

News

Government agrees to indemnify companies...

17.04.2020

News

Spotlight on IVDR – Will the European...

23.05.2022

News

What does “quality” mean when it...

05.10.2021

News

Will Private Equity make waves in the life...

20.04.2021

News

Competition Law Focus on Healthcare Markets...

06.12.2023

News

Reasons to be optimistic in 2023

26.04.2023

News

mRNA Vaccines: a growing and complex IP landscape

28.09.2022

News

University spinouts

01.08.2022

News

National Security and Investment Act: Impact on...

28.04.2022

News

Team-NB issues a cry for help and some slight...

13.01.2021

News

MHRA warning about “certificates of...

05.08.2020

News

VPAS – If you thought 15% was a shock, get...

21.09.2022

News

Cell therapies: an introduction

16.06.2022

News

Spotlight on IVDR – Why we keep banging on...

12.05.2022

News

Pricing of branded medicines: Amendments to the...

06.04.2022

News

VPAS: One-off repayment rate for 2022 announced

11.02.2022

News

MDR Notified Bodies – the stroll-out continues

16.09.2021

News

26 May 2020 – a medical device milestone missed

26.05.2020

News

Disputes over FRAND licensing in the automotive...

09.04.2020

News

Bristows’ article series on mRNA referenced...

13.09.2022

News

The Price is Not Right: Competition authorities...

23.07.2020

News

Hallelujah! Plans to extend IVDR transitional...

18.10.2021

News

IVDR Notified Bodies – here comes the crunch

16.09.2021

News

Transforming public procurement – goodbye red...

25.08.2021

News

Updated CMA merger guidance as NSI Act comes into...

07.01.2022

News

Should the CMA investigate the music industry?

12.08.2021

News

Coronavirus: what impact is it having on current...

16.04.2020

News

COVID-19 and sick pay

13.03.2020

Article

COVID-19 tax measures

19.03.2020

Article

COVID-19: Company Annual General Meetings

14.07.2020

Article

Updated COVID-19 Business Loan Schemes: support...

04.05.2020

Article

COVID-19: The UK Government’s temporary...

03.04.2020

Article

The post pandemic workplace – key...

13.06.2022

Article

COVID-19 emergency tax measures

23.03.2020

Article

Government financial support for large...

27.03.2020

Article

Making sure they take notice: Complying with...

14.07.2020

Article

COVID 19 – tenant protection measures update

29.06.2020

Article

Have regulatory procedures for medical devices...

09.03.2021

Article

COVID-19: Emergency volunteering leave

07.04.2020

Article

COVID-19: Restrictions on aggressive rent...

24.04.2020

Article

Autumn Budget 2021: Tax highlights

27.10.2021

Article

COVID-19 2020 rating measures

23.03.2020

Article

A careful balance: injunctions, patentees’...

22.12.2020

Article

Planning reforms 2020

05.08.2020

Article

Coronavirus Job Retention Scheme – Updated...

07.04.2020

Article

Coronavirus Job Retention Scheme: FAQs for...

27.03.2020

Article

COVID-19: Data protection and information...

17.04.2020

Article

COVID-19: Proposed amendments to insolvency law...

07.04.2020

Article

Dom Adair and Luke Maunder quoted on IAM

21.08.2020

Article

COVID 19 – tenant protection measures extended

18.09.2020

Article

COVID-19: Protection for commercial tenants

24.03.2020

Article

Working from home? Dos and don’ts for...

10.06.2020

Article

The post-Brexit UK-EU trading relationship

09.06.2020

Article

Spring Budget 2021: Tax highlights

04.03.2021

Article

Budget 2020: Tax highlights

11.03.2020

Article

Further extension to the CJRS

12.01.2021

Article

“Trust me, I’m an algorithm”

01.12.2021

Article

Social media: To regulate or not to regulate?

19.06.2020

Article

How companies can provide UK visa support for...

17.03.2022

Article

Digital transformation and the new wave of...

13.01.2022

Article

The House of Commons Digital, Culture, Media and...

08.09.2021

Article

Please mind the gap – expedition of patent...

21.09.2021

Article

New HMRC guidance: VAT and SDLT on lease...

05.08.2020

Article

Accessibility by Design (AbD)

28.08.2020

Article

Back to work?

01.06.2020

Article

Search Results for covid

VIEW:

Claire Smith

Erik Müürsepp

Lucie Fortune

Simon McDougall

Chartered Institute of Taxation (CIOT)’s...

Pharmaceutical round-up: competition, regulation...

The latest on competition law in the COVID-19...

One Nucleus’ Building Life Science Adventures...

Will AI save the world from another pandemic?

C5’s 17th Annual Forum on Pharma &...

LESI 2021 Annual Conference: Maximizing the value...

OxView’s 8th Intellectual Property and...

Patent review of the year seminar

Transparency – How to get the message across

Advanced EU Competition Law: Digital edition

SCL Tea & Tech Two

The modern space race: Vaccine rollout and the...

UK government approach to COVID-19 therapeutics...

Public Health England ‘approves’ Roche...

Collaboration: Sustainable future or dangerous...

Animal vaccines: COVID-19 and beyond

Spotlight on mRNA – IP landscape

Spotlight on mRNA – Regulation of mRNA vaccines...

Releasing the Therapeutic GMO

The importance of pandemic preparedness

European Commission resurrects comfort letters to...

COVID-19 and its impact on Competition Law for...

In response to COVID-19, the European Commission...

COVID-19: Key implications for digital...

UK and Europe back exemptions – more medical...

MHRA approves Janssen COVID-19 vaccine

UK announce new ventilator requirements in the...

mRNA patent litigation…the new patent wars?

How is COVID-19 impacting competition law for the...

Government updates ventilator challenge minimum...

Spotlight on mRNA – Recent deal activity

The small difference making big waves: Why...

Charlie French quoted in the Financial Times and...

Coronavirus and contact tracing apps

Priorities for academic organisations in...

Artificial intelligence-assisted medical imaging...

Spotlight on mRNA – What is mRNA and what...

Avoiding bias and increasing diversity in AI and...

Q&A – The industry perspective

Viral vectors: shortages and innovation

Five Life Sciences trends for 2022

How COVID-19 has impacted the adtech industry

Smoother sailing for sanitisers

Commission delays MDR by 12 months

Fortnite takes on Apple’s App Store in Epic...

AI and medical devices – Our experts answer...

Gilead’s remdesivir granted conditional...

Government writes to medicine suppliers...

Looking ahead to the EU In Vitro Diagnostic...

Spin-outs: What will 2021 hold for UK...

Spotlight on mRNA – A brief history of mRNA...

Webinar: Will AI save the world from another...

Will the new pharmaceutical strategy for Europe...

Notified Bodies – An update

CLIP of the month: Could patent pools help combat...

Uncertain times: Changes to the UK’s tax regime

Biotech is in for a rollercoaster 2021

Webinar: Transparency – how to get the message...

Fiona Nicolson launches three briefings, written...

Avoiding bias and increasing diversity in AI and...

European Commission publishes Common...

Test and trace in the world of data protection

Regulatory T cells: the next wave of cell therapy

CRISPR-Cas9 – from Nobel prizes to priority

‘Full throttle’: venture capital in...

The UK’s genomic future

CLIP of the month: safeguarding pro-competitive...

Working in the metaverse – what employers...

The regulation of software medical devices

“Regulation is back” for IT and technology...

Implementation deadlines for the EU In Vitro...

Innovation Passports and the ILAP: A new and...

BIA announces another record year of UK biotech...